MRNA Jan 2025 175.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:40AM EDT. Market open.
Loading interactive chart...
- Zacks
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.
- Insider Monkey
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Moderna, Inc. (NASDAQ:MRNA) is the top gene therapy stock to invest in now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
© 2024 Yahoo. All rights reserved.